Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Designed human serum hyaluronidase 1 variant, HYAL1DeltaL, exhibits activity up to pH 5.9.
Reitinger S, Müllegger J, Greiderer B, Nielsen JE, Lepperdinger G.
???displayArticle.abstract???
Hyaluronidases from diverse species and sources have different pH optima. Distinct mechanisms with regard to dynamic structural changes, which control hyaluronidase activity at varying pH, are unknown. Human serum hyaluronidase 1 (HYAL1) is active solely below pH 5.1. Here we report the design of a HYAL1 variant that degrades hyaluronan up to pH 5.9. Besides highly conserved residues in close proximity of the active site of most hyaluronidases, we identified a bulky loop formation located at the end of the substrate binding crevice of HYAL1 to be crucial for substrate hydrolysis. The stretch between cysteine residues 207 and 221, which normally contains 13 amino acids, could be replaced by a tetrapeptide sequence of alternating glycine serine residues, thereby yielding an active enzyme with an extended binding cleft. This variant exhibited hyaluronan degradation at elevated pH. This is indicative for appropriate substrate binding and proper positioning being decisively affected by sites far off from the active center.
Arnold,
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.
2006, Pubmed
Arnold,
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.
2006,
Pubmed Bairoch,
The ENZYME database in 2000.
2000,
Pubmed Chao,
Structure of human hyaluronidase-1, a hyaluronan hydrolyzing enzyme involved in tumor growth and angiogenesis.
2007,
Pubmed Cherr,
The PH-20 protein in cynomolgus macaque spermatozoa: identification of two different forms exhibiting hyaluronidase activity.
1996,
Pubmed Csóka,
Purification and microsequencing of hyaluronidase isozymes from human urine.
1997,
Pubmed Frost,
Purification, cloning, and expression of human plasma hyaluronidase.
1997,
Pubmed Gmachl,
The human sperm protein PH-20 has hyaluronidase activity.
1993,
Pubmed Guex,
SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.
1997,
Pubmed Henrissat,
Updating the sequence-based classification of glycosyl hydrolases.
1996,
Pubmed Jorgensen,
The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin.
1988,
Pubmed Joshi,
Dissecting the electrostatic interactions and pH-dependent activity of a family 11 glycosidase.
2001,
Pubmed Kreil,
Hyaluronidases--a group of neglected enzymes.
1995,
Pubmed Lepperdinger,
Hyal2--less active, but more versatile?
2001,
Pubmed
,
Xenbase Marković-Housley,
Crystal structure of hyaluronidase, a major allergen of bee venom.
2000,
Pubmed Menzel,
Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses.
1998,
Pubmed Meyer,
The soluble hyaluronidase from bull testes is a fragment of the membrane-bound PH-20 enzyme.
1997,
Pubmed Müllegger,
Hapten-labeled hyaluronan, a substrate to monitor hyaluronidase activity by enhanced chemiluminescence-assisted detection on filter blots.
2001,
Pubmed Müllegger,
Degradation of hyaluronan by a Hyal2-type hyaluronidase affects pattern formation of vitelline vessels during embryogenesis of Xenopus laevis.
2002,
Pubmed
,
Xenbase Natowicz,
Human serum hyaluronidase: characterization of a clinical assay.
1996,
Pubmed Nielsen,
Optimizing the hydrogen-bond network in Poisson-Boltzmann equation-based pK(a) calculations.
2001,
Pubmed Nielsen,
On the evaluation and optimization of protein X-ray structures for pKa calculations.
2003,
Pubmed Nielsen,
Analysing the pH-dependent properties of proteins using pKa calculations.
2007,
Pubmed Nielsen,
Improving macromolecular electrostatics calculations.
1999,
Pubmed Oettl,
Comparative characterization of bovine testicular hyaluronidase and a hyaluronate lyase from Streptococcus agalactiae in pharmaceutical preparations.
2003,
Pubmed Podyma,
Difference of hyaluronidase produced by human tumor cell lines with hyaluronidase present in human serum as revealed by zymography.
1997,
Pubmed Reitinger,
Mouse testicular hyaluronidase-like proteins SPAM1 and HYAL5 but not HYALP1 degrade hyaluronan.
2007,
Pubmed
,
Xenbase Reitinger,
Xenopus kidney hyaluronidase-1 (XKH1), a novel type of membrane-bound hyaluronidase solely degrades hyaluronan at neutral pH.
2001,
Pubmed
,
Xenbase Reitinger,
High-yield recombinant expression of the extremophile enzyme, bee hyaluronidase in Pichia pastoris.
2008,
Pubmed Skov,
Structure of recombinant Ves v 2 at 2.0 Angstrom resolution: structural analysis of an allergenic hyaluronidase from wasp venom.
2006,
Pubmed Søndergaard,
Determination of electrostatic interaction energies and protonation state populations in enzyme active sites.
2008,
Pubmed Vriend,
WHAT IF: a molecular modeling and drug design program.
1990,
Pubmed
